Erythropoietin and Platelet Activation Markers
NCT01392612
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Thrombosis
Hypertension
Interventions
DRUG:
erythropoietin
Sponsor
Medical University of Vienna